Colocalisation of matrix metalloproteinase-9-mRNA and protein in human colorectal cancer stromal cells

British Journal of Cancer

Volumn 74, Issue 8, 1996, Pages 1161-1167

  Zeng, Z S ^a   Guillem, J G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

92 type IV collagenase; Colorectal cancer; Macrophage; Matrix metalloproteinase

Indexed keywords

GELATINASE B; MESSENGER RNA;

ARTICLE; CANCER INVASION; CELL INTERACTION; CLINICAL ARTICLE; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERPHASE; MACROPHAGE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; STROMA CELL; TUMOR CELL;

EID: 0029842329     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.511     Document Type: Article

References (61)

1. BALLIN M, GOMEZ DE, SINHA CC AND THORGEIRSSON UP. (1988). Ras oncogene mediated induction of a 92kDa metalloproteinase: strong correlation with the malignant phenotype. Biochem. Biophys. Res. Commun., 154, 832 - 838.
2. BASSET P, BELLOCQ JP, WOLF C, STOLL I, LIMACHER JM, PODHAJCER OL, CHENARD MP, RIO MC AND CHAMBON P. (1990). A novel metalloproteinase gene specifically expressed in stromal cell of breast carcinomas. Nature, 348, 699 - 704.
3. BERNHARD EJ, GRUBER SB AND MUSCHEL RJ. (1994). Direct evidence linking expression of matrix metalloproteinase 9 (92 kDa genatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc. Natl Acad. Sci. USA, 91, 4293 - 4297.
4. BIRKEDAL-HANSEN H. (1995). Proteolytic remodeling of extracellular matrix. Curr. Opin. Cell Biol., 7, 728 - 735.
5. BIRKEDAL-HANSEN H, MOORE WG, BODDEN MK, WINDSOR LJ, BIRKEDAL-HANSEN B, DECARLO A AND ENGLER JA. (1993). Matrix metalloproteinases: a review (review). Crit. Rev. Oral Biol. Med., 4, 197 - 250.
6. BROWN PD, BLOXIDGE RE, STUART NSA, GATTER KC AND CARMICHAEL J. (1993). Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma. J. Natl Cancer Inst., 85, 574 - 578.
7. CANETE-SOLER R, LITZKY L, LUBENSKY I AND MUSCHEL RJ. (1994). Localization of the 92 kd gelatinase mRNA in squamous cell and adenocarcinomas of the lung using in situ hybridization. Am. J. Pathol., 144, 518 - 527.
8. COTTAM DW AND REES RC. (1993). Regulation of matrix metalloproteinases: their role in tumor invasion and metastases (review). Int. J. Oncol., 2, 861 - 872.
9. DAVIES B, MILES DW, HAPPERFIELD LC, NAYLOR MS, BOBROW LG, RUBENS RD AND BALKWILL FR. (1993a). Activity of type IV collagenases in benign and malignant breast disease. Br. J. Cancer, 67, 1126 - 1131.
10. DAVIES B, WAXMAN J, WASAN H, ABEL P, WILLIAMS G, KRAUSZ T, NEAL D, THOMAS D, HANBY A AND BALKWILL F. (1993b). Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res., 53, 5365 - 5369.
11. EMMERT-BUCK MR, ROTH MJ, ZHUANG Z, CAMPO E, ROZHIN J, SLOANE BF AND STETLER-STEVENSON WG. (1994). Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. Am. J. Pathol., 145, 1285 - 1290.
12. EMONARD HP, REMACLE AG, NOEL AC, GRIMAUD JA, STETLER-STEVENSON WG AND FOIDART JM. (1992). Tumor cell surface-associated binding site for the M(r) 72,000 type IV collagenase. Cancer Res., 52, 5845 - 5848.
13. FRIDMAN R, TOTH M, PENA D AND MOBASHERY S. (1995). Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res., 55, 2548 - 2555.
14. GUILLEM JG, LEVY MF, HSIEH LL, JOHNSON MD, LOGERFO P, FORDE KA AND WEINSTEIN IB. (1990). Increased levels of phorbin, c-myc, and ornithine decarboxylase RNAs in human colon cancer. Mol. Carcinog., 3, 68 - 74.
15. HAMDY FC, FADLON D, COTTAM D, LAWRY J, THURRELL W, SILCOCKS PB, ANDERSON JB, WILLIAMS JL AND REES RC. (1994). Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia. Br. J. Cancer, 69, 177 - 182.
16. JEZIORSKA M, HABOUBI NY, SCHOFIELD PF, OGATA Y, NAGASE H AND WOOLLEY DE. (1994). Distribution of gelatinase B (MMP-9) and type IV collagen in colorectal carcinoma. Int. J. Colorectal Dis., 9, 141 - 148.
17. KATAOKA H, DECASTRO R, ZUCKER S AND BISWAS C. (1993). Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase. Cancer Res., 53, 3154 - 3158.
18. KOSSAKOWSKA AE, URBANSKI SJ, WATSON A, HAYDEN LJ AND EDWARDS DR. (1993). Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas. Oncol. Res., 5, 19 - 28.
19. LEVY AT, CIOCE V, SOBEL ME, GARBISA S, GRIGIONI WF, LIOTTA LA AND STETLER-STEVENSON WG. (1991). Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma. Cancer Res., 51, 439 - 444.
20. LIOTTA LA, STEEG PS AND STETLER STEVENSON WG. (1991). Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64, 327 - 336.
21. MCDONNELL S, NAVRE M, COEFEY RJJ AND MATRISIAN LM. (1991). Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas. Mol. Carcinog., 4, 527 - 533.
22. MACKAY AR, BALLIN M, PELINA MD, FARINA AR, NASON AM, HARTZLER JL AND THORGEIRSSON UP. (1992). Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Invasion Metastasis, 12, 168 - 184.
23. MANTOVANI A AND SEMERARO N. (1995). Tumor associated macrophages and their modulatory role in tumor progression. In Tumor Matrix and Biology, Adany R. (ed.) pp. 173 - 188. CRC Press, Inc.: New York.
24. MATRISIAN LM. (1992). The matrix-degrading metalloproteinases. Bioessays, 14, 455 - 463.
25. MOLL UM, YOUNGLEIB GL, ROSINSKI KB AND QUIGLEY JP. (1990). Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells. Cancer Res., 50, 6162 - 6170.
26. MULLER D, BREATHNACH R, ENGELMANN A, MILLON R, BRONNER G, FLESCH H, DUMONT P, EBER M AND ABECASSIS J. (1991). Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumours. Int. J. Cancer, 48, 550 - 556.
27. NAKAJIMA M, MORIKAWA K, FABRA A, BUCANA CD AND FIDLER IJ. (1990). Influence of organ environment on extracellular matrix degradative activity and metastasis of human colon carcinoma cells. J. Natl Cancer Inst., 182, 1890 - 1898.
28. NAYLOR MS, STAMP GW, DAVIES BD AND BALKWILL FR. (1994). Expression and activity of MMPs and their regulators in ovarian cancer. Int. J. Cancer, 58, 50 - 56.
29. NEWELL KJ, WITTY JP, RODGERS WH AND MATRISIAN LM. (1994). Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis. Mol. Carcinog., 10, 199 - 206.
30. NIELSEN BS, TIMSHEL S, KJELDSEN L, SEHESTED M, PYKE C, BORREGAARD N AND DANO K. (1996). 92kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer. Int. J. Cancer, 65, 57 - 62.
31. NOEL A, SANTAVICCA M, STOLL I, L'HOIR C, STAUB A, MURPHY G, RIO M AND BASSET P. (1995). Identification of structural determinants controlling human and mouse stromelysin-3 proteolytic activities. J. Biol. Chem., 270, 22866 - 22872.
32. POULSOM R, PIGNATELLI M, STETLER STEVENSON WG, LIOTTA LA, WRIGHT PA, JEFFERY RE, LONGCROFT JM, ROGERS L AND STAMP GW. (1992). Stromal expression of 72kDa type IV collagenase (mmp-2) and timp-2 mRNAs in colorectal neoplasia. Am. J. Pathol., 141, 389 - 396.
33. PUENTE XS, PENDAS AM, LLANO E, VELASCO G AND LOPEZ-OTIN C. (1996). Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res., 56, 944 - 949.
34. PULFORD KAF, RIGNEY EM, MICKLEM KJ, JONES M, STROSS WP, GATTER KC AND MASON DR (1989). KP1: a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue section. J. Clin. Pathol., 42, 414 - 421.
35. PYKE C, RALFKIAER E, HUHTALA P, HURSKAINEN T, DANO K AND TRYGGVASON K (1992). Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. Cancer Res., 52, 1336 - 1341.
36. PYKE C, RALKIAER E, TRYGGVASON K AND DANO K. (1993). Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am. J. Pathol., 142, 359 - 365.
37. RAMOS-DESIMONE N, MOLL UM, QUIGLEY JP AND FRENCH DL. (1993). Inhibition of matrix metalloproteinase 9 activation by a specific monoclonal antibody. Hybridoma, 12, 349 - 363.
38. RAO, JS, STECK PA, MOHANAM S, STETLER-STEVENSON WG, LIOTTA LA AND SAWAYA R. (1993). Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors. Cancer Res., 53, 2208 - 2211.
39. SAARIALHO-KERE UK, CHANG ES, WELGUS HG AND PARKS WC. (1993). Expression of interstitial collagenase, 92-kDa gelatinase, and tissue inhibitor of metalloproteinases-1 in granuloma annulare and necrobiosis lipoidica diabeticorum. J. Invest. Dermatol., 100, 335 - 342.
40. SATO H, TAKINO T, OKADA Y, CAO J, SHINAGAWA A, YAMAMOTO E AND SEIKI M. (1994). A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature, 370, 61 - 65.
41. SLEDGE JR GW, QULALI M, GOULET R, BONE EA AND FIFE R. (1995). Effect of matrix metalloproteinase inhibitor batimastar on breast cancer regrowth and metastasis in athymic mice. J. Natl Cancer Inst., 87, 1546 - 1550.
42. AHLE-BACKDAHL M AND PARKS WC. (1993). 92-kd gelatinase is actively expressed by eosinophils and stored by neutrophils in squamous cell carcinoma. Am. J. Pathol., 142, 995 - 1000.
43. STEARNS ME AND WANG M. (1993). Type IV collagenase (M(r) 72,000) expression in human prostate: benign and malignant tissue. Cancer Res., 53, 878 - 883.
44. SWALLOW CJ, MURRAY MP AND GUILLEM JG. (1996). Metastatic colorectal cancer cells induce matrix metalloproteinase release by human monocytes. Clin. Exp. Metastasis, 14, 3 - 11.
45. TAKINO T, SATO H, SHINAGAWA A AND SEIKI M. (1995). Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. J. Biol. Chem., 270, 23013 - 23020.
46. THALMEIER K, MEISSNER P, REISBACH G, FALK M, BRECHTEL A AND DORMER P. (1994). Establishment of two permanent human bone marrow stromal cell lines with long-term post irradiation feeder capacity. Blood, 83, 1799 - 1807.
47. TRYGGVASON K, HOYHTYA M AND PYKE C. (1993). Type IV collagenases in invasive tumors. Breast Cancer Res. Treat., 24, 209 - 218.
48. TURPEENNIEMI-HUJANEN T, THORGEIRSSION UP, HART IR, GRANT SS AND LIOTTA LA. (1985). Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastastic potential. J. Natl Cancer Inst., 75, 99 - 103.
49. WERB Z AND ALEXANDER CM. (1993). Proteinase and matrix degradation. In Textbook of Rheumatology, Kelley WN, Harris JRED, Ruddy S and Sledge CB. (ed.) pp. 248 - 268. WB Saunders Company: Philadelphia.
50. WILL H AND HINZMANN B. (1985). cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur. J. Biochem., 231, 602 - 608.
51. WOESSNER JF JR. (1994). The family of matrix metalloproteinases. Ann. N. Y. Acad. Sci., 732, 11 - 21.
52. WOLF C, ROUYER N, LUTZ Y, ADIDA C, LORIOT M, BELLOCQ JP, CHAMBON P AND BASSET P, (1993). Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression. Proc. Natl Acad. Sci. USA, 90, 1843 - 1847.
53. WUCHERPFENNIG AL, LI YP, STETLER-STEVENSON WG, ROSENBERG AE AND STASHENKOP. (1994). Expression of 92 kD type IV collagenase/gelatinase B in human osteoclasts. J. Bone Mineral Res., 9, 549 - 556.
54. YAMAGATA S, ITO Y, TANAKA R AND SHIMIZU S. (1988). Gelatinases of metastatic cell lines of murine colonic carcinoma as detected by substrate-gel electrophoresis. Biochem. Biophys. Res. Commun., 151, 158 - 162.
55. YOSHIMOTO M, ITOH F, YAMAMOTO H, HINODA Y, IMAI K AND YACHI A. (1993). Expression of MMP-7 (PUMP-1) mRNA in human colorectal cancers. Int. J. Cancer, 54, 614 - 618.
56. YOUNG TN, PIZZO SV AND STACK MS. (1995). A plasma membrane-associated component of ovarian adenocarcinoma cells enhances the catalytic efficiency of matrix metalloproteinase-2. J. Biol. Chem., 270, 999 - 1002.
57. YU M, SATO H, SEIKI M AND THOMPSON EW. (1995). Complex regulation of membrane- type matrix metalloproteinases expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells. Cancer Res., 55, 3272 - 3277.
58. ZENG ZS AND GUILLEM JG. (1995). Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases. Br. J. Cancer, 72, 575 - 582.
59. ZENG ZS, HSU S, ZHANG ZF, COHEN ZM, ENKER WE, TURNBULL AA AND GUILLEM JG. (1994a). High level of Nm23-H1 gene expression is associated with local colorectal cancer progression not with metastases. Br. J. Cancer, 70, 1025 - 1030.
60. ZENG ZS, SARKIS AS, ZHANG ZF, KLIMSTRA DS, CHARYTONOWICZ E, GUILLEM JG, CORDON-CARDO C AND COHEN AM. (1994b). p53 nuclear overexpression: an independent predictor of survival in lymph node-positive colorectal cancer patients. J. Clin. Oncol., 12, 2043 - 2050.
61. ZENG ZS, COHEN AM AND GUILLEM JG. (1995). Secretion of activated matrix metalloproteinases-2 and 9 is associated with metastases in human colorectal cancer. Proc. Annu. Meet. Am. Assoc. Cancer Res., 36, 78.